LPS endotoxemia results in the upregulation of TLR4, promotes NF-κB transcription, and induces the overproduction of inflammatory cytokines that induce chronic low-grade inflammation, ultimately leading to NAFLD [26]. The gene discussed is TLR4; the disease is metabolic dysfunction-associated steatotic liver disease.